Skeljungur hf.
25.3.2021 08:23:26 CET | Globenewswire | Press release
The board of directors of Skeljungur hf. has made a decision to assess the advantages of future ownership of P/F Magn, Skeljungur’s subsidiary in the Faroe Islands. The internal organisation of P/F Magn will be scrutinised to evaluate whether Skeljungur’s advantages lie in external or organic growth or in selling the company, in part or in full.
Skeljungur will be advised by a corporate advisory team from Kvika Bank hf.
P/F Magn operates 11 retail and fuel outlets across the Faroe Islands, addition to operating two fuel depots and distributing fuel to corporations, contractors and fisheries operators. Magn leads the market in sales of fuel for house heating in the Faroe Islands, where most housing is heated using oil. Following the acquisition by Magn of the company P/F Demich, which specialises in environmentally sound house heating solutions, Magn will be able to offer comprehensive house heating solutions regardless of the energy chosen by customers for their heating.
P/F Magn’s total income in the operating year 2020 amounted to ISK 15,560 million, while the Group total income amounted to ISK 41,203 million. P/F Magn’s EBITDA in 2020 amounted to ISK 1,509 million, while the Group EBITDA amounted to ISK 2,676 million.
Further news may be expected in the coming months.
For further information, please contact Árni Pétur Jónsson, CEO fjarfestar@skeljungur.is.
www.skeljungur.is
https://www.linkedin.com/company/skeljungur-hf/
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Newcap Holdings29.3.2026 12:19:20 CEST | Pressemeddelelse
NewCap Holding A/S har indgået en aftale, betinget af underskrivelse af endelige aftaledokumenter m.v., om erhvervelse af dansk selskab indenfor compliance og risikostyringsservices – Intern viden
Novartis Pharma AG29.3.2026 07:15:00 CEST | Press release
Novartis IgAN data in New England Journal of Medicine show Fabhalta® slowed kidney function decline by 49.3%
Biogen Inc.28.3.2026 20:00:00 CET | Press release
Biogen Announces Second Positive Phase 2 Litifilimab Trial in Cutaneous Lupus Erythematosus at 2026 American Academy of Dermatology Annual Meeting, Showing a Significant Reduction in Skin Disease Activity
MoonLake Immunotherapeutics AG28.3.2026 20:00:00 CET | Press release
MoonLake announces Week 40 Results from its Phase 3 Clinical Trials of Sonelokimab in Hidradenitis Suppurativa at the 2026 AAD Annual Meeting
Sanofi Winthrop Industrie28.3.2026 16:00:00 CET | Press release
Press Release: AAD: new results from Sanofi's amlitelimab phase 3 studies in atopic dermatitis presented in late-breaking research session
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
